Sun Pharma served with tax demand of Rs 1.11 crore
Mumbai: Sun Pharmaceutical Industries has been served with a tax demand of over Rs 1.11 crore by authorities, citing disallowed input tax credit.
As per the recent BSE filing, the company has received an order from the Joint Commissioner, CGST and Central Excise, passed under the GST Act, raising a demand of Rs 1,11,60,156, imposing a penalty of Rs 11,16,016 and interest as applicable.
Sun Pharma is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult-to-make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs), and Intermediates.
Read also: Sun Pharma Advanced Research Company halts Parkinson's disease drug trial
